Immunoglobulin Igg2
Immunoglobulin Igg2 Uses, Dosage, Side Effects, Food Interaction and all others data.
Immunoglobulin Igg2 is under investigation in clinical trial NCT04031742 (A Study to Evaluate Safety and Efficacy of IBI306, a PCSK9 Monoclonal Antibody in Chinese Subjects With Homozygous Familial Hypercholesterolemia).
| Trade Name | Immunoglobulin Igg2 |
| Generic | Tafolecimab |
| Tafolecimab Other Names | Immunoglobulin igg2, anti-(human proprotein convertase subtilisin/kexin type 9) (human monoclonal ibi306 .gamma.2-chain), disulfide with human monoclonal ibi306 .kappa.-chain, dimer, Tafolecimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Immunoglobulin Igg2
